跳至主要内容
临床试验/NCT03752476
NCT03752476Unknown不适用

Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria

Centre Hospitalier Universitaire de Besancon0 个研究点目标入组 1,300 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,300
主要终点
number of Beta lactam class prescription

研究概览

简要总结

This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care

It's retrospective case controle study. Cases are colonized patient by multidrug resistant bacteria hospitalized in intensive care during the fist hospitalization in intensive care. Temoin are patients with the same characteristics than case but no colonized by multidrug resistant bacteria.

详细描述

The emergence of multidrug resistant is a wordwide problem. B lactam resistant increase. The antibiotic prescription impact this problem.

B lactam antibiotic is prescribed everyday in intensive care unit. The switch of antibiotic is common. Antibiotic classes inclue a lot of rank with different spectum that impact the occurrence of resistant.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patient hospitalized more than 48 hours in intensive care unit in Besançon between january 2016 and december 2017

排除标准

  • patient under guardianship
  • patient allergic to Beta lactam
  • colonization with mutidrug resistant the first week of hospitalization in intensive care unit

结局指标

主要结局

number of Beta lactam class prescription

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Estelle Dossot

Internal

Centre Hospitalier Universitaire de Besancon

相似试验